To establish whether the decrease in TIM-3 expression on NK cells is unique to the U87MG cancer cell line, we exposed NK cells to prostate cancer (PC3) and patient-derived glioblastoma (GBM43) cells. This evidence concerns the gene HAVCR2 and prostate carcinoma.